Stay updated on Migraine Insights & Galcanezumab Mechanisms Clinical Trial
Sign up to get notified when there's something new on the Migraine Insights & Galcanezumab Mechanisms Clinical Trial page.

Latest updates to the Migraine Insights & Galcanezumab Mechanisms Clinical Trial page
- Check2 days agoChange DetectedRevision: v3.5.0 was added and v3.4.3 was removed, updating the page's version indicator.SummaryDifference0.1%

- Check9 days agoChange DetectedThe page's revision label was updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check24 days agoChange DetectedNew record history entries add sections for Adverse Events, Outcome Measures, Baseline Characteristics, Participant Flow, and Study Status, with QC notes. Date annotations such as 2026-02-20 and 2026-02-04 are now visible.SummaryDifference1%

- Check38 days agoChange DetectedThe record history now includes a 'Results Submitted' entry and a new version labeled 'Revision: v3.4.2'.SummaryDifference0.9%

- Check45 days agoChange DetectedAdded a site-wide notice about government funding status and updated the record version to v3.4.1; removed the previous version label v3.4.0.SummaryDifference0.8%

- Check52 days agoChange DetectedA 2026-01-23 revision adds a 'Completed' study status and introduces color-coded diffs (green additions, red deletions) along with UI cues like 'Show glossary'. The 2026-01-22 entry adds No FEAR Act Data and notes Revision: v3.4.0, while the previous 'Active, not recruiting' status is removed.SummaryDifference2%

Stay in the know with updates to Migraine Insights & Galcanezumab Mechanisms Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Migraine Insights & Galcanezumab Mechanisms Clinical Trial page.